³í¹®) Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data
¼¿ï´ëº´¿ø(¿øÀå ±è¿¬¼ö) ºñ´¢ÀÇÇаú Á¤Ã¢¿í(»çÁø ÁÂ)·°ûö(¿ì) ±³¼öÆÀ